Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Mallinckrodt
Merck
Express Scripts
Johnson and Johnson

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Hydrochlorothiazide; reserpine - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for hydrochlorothiazide; reserpine and what is the scope of freedom to operate?

Hydrochlorothiazide; reserpine is the generic ingredient in eleven branded drugs marketed by Whiteworth Town Plsn, Abc Holding, Sandoz, Ivax Sub Teva Pharms, Pharmeral, Roxane, Watson Labs, Merck, Barr, West Ward, and Novartis, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-two drug master file entries for hydrochlorothiazide; reserpine.

Summary for hydrochlorothiazide; reserpine
Recent Clinical Trials for hydrochlorothiazide; reserpine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
West China HospitalPhase 4
VA Office of Research and DevelopmentN/A

See all hydrochlorothiazide; reserpine clinical trials

Synonyms for hydrochlorothiazide; reserpine
C33H40N2O9.C7H8ClN3O4S2
H.R.-50
HYDRO-RESERP
HYDRO-SERP "25"
HYDRO-SERP "50"
HYDROCHLOROTHIAZIDE W/ RESERPINE
LS-178646
RESERPINE AND HYDROCHLOROTHIAZIDE
RESERPINE AND HYDROCHLOROTHIAZIDE-50
SCHEMBL4265419

US Patents and Regulatory Information for hydrochlorothiazide; reserpine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck HYDROPRES 50 hydrochlorothiazide; reserpine TABLET;ORAL 011958-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Ivax Sub Teva Pharms HYDROCHLOROTHIAZIDE W/ RESERPINE hydrochlorothiazide; reserpine TABLET;ORAL 083568-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Ivax Sub Teva Pharms HYDROCHLOROTHIAZIDE W/ RESERPINE hydrochlorothiazide; reserpine TABLET;ORAL 083572-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs HYDROCHLOROTHIAZIDE W/ RESERPINE hydrochlorothiazide; reserpine TABLET;ORAL 084466-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Moodys
Harvard Business School
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.